-
公开(公告)号：US20060063814A1
公开(公告)日：2006-03-23
申请号：US11225950
申请日：2005-09-14
申请人： Robert Goodnow, , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
发明人： Robert Goodnow, , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
IPC分类号： A61K31/427 , C07D417/02
CPC分类号： C07D417/14 , C07D417/12
摘要： The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及式的化合物
-
公开(公告)号：US20060041146A1
公开(公告)日：2006-02-23
申请号：US11202299
申请日：2005-08-11
申请人： Xin-Jie Chu , Nader Fotouhi , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
发明人： Xin-Jie Chu , Nader Fotouhi , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
IPC分类号： A61K31/427 , C07D417/02
CPC分类号： C07D417/12 , C07D417/14
摘要： The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及可用于治疗以MEK多动症为特征的疾病的下式化合物。 因此，该化合物可用于治疗诸如癌症，认知和CNS障碍和炎症/自身免疫性疾病的疾病。
-
公开(公告)号：US07427635B2
公开(公告)日：2008-09-23
申请号：US11202299
申请日：2005-08-11
申请人： Xin-Jie Chu , Nader Fotouhi , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Moliterni , Zhuming Zhang
发明人： Xin-Jie Chu , Nader Fotouhi , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Moliterni , Zhuming Zhang
IPC分类号： A61K31/427 , C07D417/12
CPC分类号： C07D417/12 , C07D417/14
摘要： The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及可用于治疗以MEK多动症为特征的疾病的下式化合物。 因此，该化合物可用于治疗诸如癌症，认知和CNS障碍和炎症/自身免疫性疾病的疾病。
-
公开(公告)号：US07612212B2
公开(公告)日：2009-11-03
申请号：US11657800
申请日：2007-01-25
申请人： Shaoqing Chen , Nicholas J. S. Huby , Norman Kong , Steven Gregory Mischke , John Anthony Moliterni , Hong Wang , Zhuming Zhang
发明人： Shaoqing Chen , Nicholas J. S. Huby , Norman Kong , Steven Gregory Mischke , John Anthony Moliterni , Hong Wang , Zhuming Zhang
IPC分类号： C07D233/02 , A61K31/4166
CPC分类号： C07D233/76 , C07D233/78 , C07D401/04 , C07D401/06 , C07D403/06 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/12 , C07D409/04 , C07D409/06 , C07D417/06
摘要： The present invention relates to compounds of the formula methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及其制备方法的化合物及其使用方法。 该化合物可用于治疗以MEK多动症为特征的疾病。 因此，该化合物可用于治疗诸如癌症，认知和CNS疾病以及炎性/自身免疫性疾病的疾病。
-
公开(公告)号：US20070197617A1
公开(公告)日：2007-08-23
申请号：US11657800
申请日：2007-01-25
申请人： Shaoqing Chen , Nicholas J. S. Huby , Norman Kong , Steven Gregory Mischke , John Anthony Moliterni , Hong Wang , Zhuming Zhang
发明人： Shaoqing Chen , Nicholas J. S. Huby , Norman Kong , Steven Gregory Mischke , John Anthony Moliterni , Hong Wang , Zhuming Zhang
IPC分类号： A61K31/4178 , A61K31/4166 , C07D403/02
CPC分类号： C07D233/76 , C07D233/78 , C07D401/04 , C07D401/06 , C07D403/06 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/12 , C07D409/04 , C07D409/06 , C07D417/06
摘要： The present invention relates to compounds of the formula methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及其制备方法的化合物及其使用方法。 该化合物可用于治疗以MEK多动症为特征的疾病。 因此，该化合物可用于治疗诸如癌症，认知和CNS疾病以及炎性/自身免疫性疾病的疾病。
-
公开(公告)号：US07371869B2
公开(公告)日：2008-05-13
申请号：US11225950
申请日：2005-09-14
申请人： Robert Alan Goodnow, Jr. , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Anthony Moliterni , Zhuming Zhang
发明人： Robert Alan Goodnow, Jr. , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Anthony Moliterni , Zhuming Zhang
IPC分类号： A61K31/427 , C07D409/12
CPC分类号： C07D417/14 , C07D417/12
摘要： The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
-
7.发明申请N-(2-CYANO HETEROCYCLYL) PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS 有权N-（2-氰基杂环基）吡唑并吡喃酮作为甘薯激酶抑制剂公开(公告)号：US20160272633A1
公开(公告)日：2016-09-22
申请号：US14778052
申请日：2014-03-19
申请人： Christopher DINSMORE , Peter FULLER , David GUERIN , Christopher F. THOMPSON , Qinglin PU , Mark E. SCOTT , Jason David KATZ , Ravi KURUKLASURIYA , Joshua T. CLOSE , Danielle FALCONE , Jason BRUDAKER , Hongbo ZENG , Yunfeng BAI , Jianmin FU , Norman KONG , Yumei LIU , Zhixiang ZHENG , MERCK SHARP & DOHME CORP.
发明人： Christopher Dinsmore , Peter Fuller , David Guerin , Christopher F. Thompson , Qinglin Pu , Mark E. Scott , Jason David Katz , Ravi Kuruklasuriya , Joshua T. Close , Danielle Falcone , Jason Brubaker , Hongbo Zeng , Yunfeng Bai , Jianmin Fu , Norman Kong , Yumei Liu , Zhixiang Zheng
IPC分类号： C07D471/04 , C07D519/00
CPC分类号： C07D471/04 , C07D519/00
摘要： Provided are compounds of Formula I, a JAK inhibitor, and use thereof for the treatment of JAK-mediated diseases by the application.
-
8.发明申请GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS 有权作为JANUS KINASE抑制剂的GEMYALLY取代的氰基乙基吡唑啉吡啶公开(公告)号：US20160272632A1
公开(公告)日：2016-09-22
申请号：US14778046
申请日：2014-03-19
申请人： Matthew Lloyd CHILDERS , Peter FULLER , David GUERIN , Jason David KATZ , Qinglin PU , Mark E. SCOTT , Christopher E. THOMPSON , Michelle MARTINEZ , Danielle FALCONE , Luis TORRES , Yongqi DENG , Ravi KURUKULASURIYA , Hongbo ZENG , Yunfeng BAI , Norman KONG , Yumei LIU , MERCK SHARP & DOHME CORP.
发明人： Matthew Lloyd Childers , Peter Fuller , David Guerin , Jason David Katz , Qinglin Pu , Mark E. Scott , Christopher F. Thompson , Michelle Martinez , Danielle Falcone , Luis Torres , Yongqi Deng , Ravi Kurukulasuriya , Hongbo Zeng , Yunfeng Bai , Norman Kong , Yumei Liu , Zhixiang Zheng
IPC分类号： C07D471/04 , C07D519/00
CPC分类号： C07D471/04 , C07D519/00
摘要： The instant invention provides compounds of Formula (I) which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
摘要翻译： 本发明提供了作为JAK抑制剂的式（I）化合物，因此可用于治疗JAK介导的疾病如类风湿性关节炎，哮喘，COPD和癌症。
-
公开(公告)号：US08063085B2
公开(公告)日：2011-11-22
申请号：US12331538
申请日：2008-12-10
IPC分类号： A01N43/50 , A61K31/415 , C07D407/00
CPC分类号： C07D233/74 , C07D233/78 , C07D417/14
摘要： The present invention relates to compounds of the formula methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.
摘要翻译： 本发明涉及其制备方法的化合物及其使用方法。 该化合物可用于治疗以MEK多动症为特征的疾病。 因此，该化合物可用于治疗诸如癌症，认知和CNS疾病以及炎性/自身免疫性疾病的疾病。
-
公开(公告)号：US06559164B1
公开(公告)日：2003-05-06
申请号：US09678521
申请日：2000-10-03
IPC分类号： A61K31405
CPC分类号： C07D401/14 , C07D403/14
摘要： Disclosed are novel substituted pyrroles having the formula These compounds and their pharmaceutically acceptable salts are suitable for administration to patients as continuous infusion solution and are useful in the treatment and/or control of cell proliferative disorders, in particular cancer. Also disclosed are pharmaceutical compositions containing the foregoing compounds and methods for the treatment and/or control of cancer.
摘要翻译： 公开了具有下式的新颖的取代的吡咯。这些化合物及其药学上可接受的盐适于作为连续输注溶液施用于患者，并且可用于治疗和/或控制细胞增殖性疾病，特别是癌症。 还公开了含有前述化合物的药物组合物和用于治疗和/或控制癌症的方法。
-
-
-
-
-
-
-
-
-
搜索结果
26 条记录 (耗时 0.034 秒)
